A review of deoxycorticosterone acetate-salt hypertension and its relevance for cardiovascular physiotherapy research

Journal of Physical Therapy Science

Volumn 27, Issue 1, 2015, Pages 303-307

  Lee, Lim Kyu ^a   Kim, Mee Young ^a   Kim, Ju Hyun ^a   Lee, Jeong Uk ^a   Park, Byoung Sun ^a   Yang, Seung Min ^a   Jeon, Hye Joo ^a   Lee, Won Deok ^a   Noh, Ji Woong ^a   Kwak, Taek Yong ^a   Lee, Tae Hyun ^a   Kim, Ju Young ^a   Kim, Hye Young ^a   Hwang, Byong Yong ^a   Kim, Bokyung ^b   Kim, Junghwan ^a  

^a Yongin University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

Cardiovascular physiotherapy; Deoxycorticosterone acetate salt hypertension; Signal transduction

Indexed keywords

EID: 84920931643     PISSN: 09155287     EISSN: None     Source Type: Journal    
DOI: 10.1589/jpts.27.303     Document Type: Review

References (52)

1. Chon KY, Kim IS, Choi KK, et al.: The noxiousness of the salt-dependent hypertension and the effect of the physical stimulation on the change of the hypertension-related sympathetic neurotransmitter. J Kor Gerontol Soc, 2004, 24: 1–11.
2. Kim JH, Kim JH: The effects of physical therapy on activation of sympathetic nerve system among older adults participating to welfare centers for the elderly. J Kor Gerontol Soc, 2010, 30: 311–322.
3. Kim JH, Lee JU, Kim IH, et al.: Noxiousness of hypertension-related norepinephrine and upregulation of norepinephrine induced by high intensity electrical stimulation in healthy volunteers. J Phys Ther Sci, 2012a, 24: 795–800. [CrossRef]
4. Kim JH, Lee LK, Lee WD, et al.: A review of signal transduction in mechanisms of smooth muscle contraction and its relevance for specialized physical therapy. J Phys Ther Sci, 2013a, 25: 129–141. [CrossRef]
5. Kim B, Kim J, Bae YM, et al.: p38 Mitogen-activated protein kinase contributes to the diminished aortic contraction by endothelin-1 in DOCA-salt hypertensive rats. Hypertension, 2004a, 43: 1086–1091. [Medline] [Cross- Ref]
6. Kim J, Lee YR, Lee CH, et al.: Mitogen-activated protein kinase contributes to elevated basal tone in aortic smooth muscle from hypertensive rats. Eur J Pharmacol, 2005, 514: 209–215. [Medline] [CrossRef]
7. Kim J, Lee CK, Park HJ, et al.: Epidermal growth factor induces vasoconstriction through the phosphatidylinositol 3-kinase-mediated mitogenactivated protein kinase pathway in hypertensive rats. J Pharmacol Sci, 2006, 101: 135–143. [Medline] [CrossRef]
8. Lee CK, Han JS, Won KJ, et al.: Diminished expression of dihydropteridine reductase is a potent biomarker for hypertensive vessels. Proteomics, 2009, 9: 4851–4858. [Medline] [CrossRef]
9. Won KJ, Lee P, Jung SH, et al.: 3-morpholinosydnonimine participates in the attenuation of neointima formation via inhibition of annexin A2- mediated vascular smooth muscle cell migration. Proteomics, 2011, 11: 193–201. [Medline] [CrossRef]
10. Dahl LK, Heine M, Tassinari L: Effects of chronia excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension. J Exp Med, 1962, 115: 1173–1190. [Medline] [CrossRef]
11. Goldblatt H, Lynch J, Hanzal RF, et al.: Studies on experimental hypertension: the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med, 1934, 59: 347–379. [Medline] [Cross- Ref]
12. Lee CK, Kim J, Won KJ, et al.: Phorbol ester-induced contraction through p38 mitogen-activated protein kinase is diminished in aortas from DOCAsalt hypertensive rats. Arch Pharm Res, 2006, 29: 1024–1031. [Medline] [CrossRef]
13. Bae YM, Kim A, Lee YJ, et al.: Enhancement of receptor-operated cation current and TRPC6 expression in arterial smooth muscle cells of deoxycorticosterone acetate-salt hypertensive rats. J Hypertens, 2007, 25: 809–817. [Medline] [CrossRef]
14. Gómez Sánchez EP: What is the role of the central nervous system in mineralocorticoid hypertension? Am J Hypertens, 1991, 4: 374–381. [Medline]
15. Aourell M, Skoog M, Carleson J: Effects of Swedish massage on blood pressure. Complement Ther Clin Pract, 2005, 11: 242–246. [Medline] [CrossRef]
16. Paterno JC, Bergamaschi CT, Campos RR, et al.: Electroacupuncture and moxibustion decrease renal sympathetic nerve activity and retard progression of renal disease in rats. Kidney Blood Press Res, 2012, 35: 355–364. [Medline] [CrossRef]
17. Lin CF, Liao JM, Tsai SJ, et al.: Depressor effect on blood pressure and flow elicited by electroacupuncture in normal subjects. Auton Neurosci, 2003, 107: 60–64. [Medline] [CrossRef]
18. Kim B, Kim J, Kim A, et al.: Ligusticum wallichi-induced vasorelaxation mediated by mitogen-activated protein kinase in rat aortic smooth muscle. J Ethnopharmacol, 2004b, 90: 397–401. [Medline] [CrossRef]
19. Won KJ, Lee SC, Lee CK, et al.: Cordycepin attenuates neointimal formation by inhibiting reactive oxygen species-mediated responses in vascular smooth muscle cells in rats. J Pharmacol Sci, 2009, 109: 403–412. [Medline] [CrossRef]
20. Katovich MJ, Soltis EE, Iloeje E, et al.: Time course alterations in vascular adrenergic responsiveness in the DOCA/NaCl-treated rat. Pharmacology, 1984, 29: 173–180. [Medline] [CrossRef]
21. Calderone A, Oster L, Moreau P, et al.: Altered protein kinase C regulation of phosphoinositide-coupled receptors in deoxycorticosterone acetate-salt hypertensive rats. Hypertension, 1994, 23: 722–728. [Medline] [CrossRef]
22. Lee YR, Lee CK, Park HJ, et al.: C-Jun N-terminal kinase contributes to norepinephrine-induced contraction through phosphorylation of caldesmon in rat aortic smooth muscle. J Pharmacol Sci, 2006, 100: 119–125. [Medline] [CrossRef]
23. Soltis EE, Field FP: Extracellular calcium and altered vascular responsiveness in the deoxycorticosterone acetate-salt rat. Hypertension, 1986, 8: 526–532. [Medline] [CrossRef]
24. Thompson LP, Webb RC: Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension. Hypertension, 1987, 9: 277–281. [Medline] [CrossRef]
25. Watts SW, Gilbert L, Webb RC: 5-Hydroxytryptamine2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats. Hypertension, 1995, 26: 1056–1059. [Medline] [CrossRef]
26. Saika T, Tsushima T, Nasu Y, et al.: Epidermal growth factor in urine from patients with bladder cancer. Urol Res, 2000, 28: 230–234. [Medline] [CrossRef]
27. Cossu M, Perra MT, Piludu M, et al.: Subcellular localization of epidermal growth factor in human submandibular gland. Histochem J, 2000, 32: 291–294. [Medline] [CrossRef]
28. Oka Y, Orth DN: Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. J Clin Invest, 1983, 72: 249–259. [Medline] [CrossRef]
29. Quigley R, Kennerly DA, Sheu JN, et al.: Stimulation of proximal convoluted tubule phosphate transport by epidermal growth factor: signal transduction. Am J Physiol, 1995, 269: F339–F344. [Medline]
30. Kashimata M, Sayeed S, Ka A, et al.: The ERK-1/2 signaling pathway is involved in the stimulation of branching morphogenesis of fetal mouse submandibular glands by EGF. Dev Biol, 2000, 220: 183–196. [Medline] [CrossRef]
31. Gregory H: Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature, 1975, 257: 325–327. [Medline] [Cross- Ref]
32. Hollenberg MD: Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci, 1994, 15: 108–114. [Medline] [CrossRef]
33. Zheng XL, Renaux B, Hollenberg MD: Parallel contractile signal transduction pathways activated by receptors for thrombin and epidermal growth factor-urogastrone in guinea pig gastric smooth muscle: blockade by inhibitors of mitogen-activated protein kinase-kinase and phosphatidyl inositol 3′-kinase. J Pharmacol Exp Ther, 1998, 285: 325–334. [Medline]
34. Fanger GR, Johnson NL, Johnson GL: MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42. EMBO J, 1997, 16: 4961–4972. [Medline] [CrossRef]
35. Rosen LB, Greenberg ME: Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. Proc Natl Acad Sci USA, 1996, 93: 1113–1118. [Medline] [CrossRef]
36. Kim JH, Choi YD, Kim MJ, et al.: Correlation between the changes in heat-induced digital infrared thermography imaging and body components in healthy volunteers. Toxicol Environ Health Sci, 2013b, 5: 107–112. [CrossRef]
37. Kim JH, Kim IH, Lee JU, et al.: Change of muscular activity and dynamic stability of the knee joint due to excessive and repetitive jumping or cutting by female athletes. J Phys Ther Sci, 2012b, 24: 715–719. [CrossRef]
38. Kim MY, Kim JH, Lee JU, et al.: Temporal changes in pain and sensory threshold of geriatric patients after moist treatment. J Phys Ther Sci, 2011, 23: 797–801. [CrossRef]
39. Kim MY, Kim JH, Lee JU, et al.: The effects of functional electrical stimulation on balance of stroke patients in the standing posture. J Phys Ther Sci, 2012, 24: 77–81. [CrossRef]
40. Lee LK, Jeon HJ, Choi YD, et al.: Change in the interferential current therapy-induced sensory threshold on the bodies of elderly people. Toxicol Environ Health Sci, 2013, 5: 41–47. [CrossRef]
41. Lee LK, Kim JH, Kim MY, et al.: A pilot study on pain and the upregulation of myoglobin through low-frequency and high-amplitude electrical stimulation-induced muscle contraction. J Phys Ther Sci, 2014, 26: 985–988. [Medline] [CrossRef]
42. Cambron JA, Dexheimer J, Coe P: Changes in blood pressure after various forms of therapeutic massage: a preliminary study. J Altern Complement Med, 2006, 12: 65–70. [Medline] [CrossRef]
43. Intengan HD, He G, Schiffrin EL: Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin- 1 in deoxycorticosterone acetate salt hypertensive rats. Hypertension, 1998, 32: 770–777. [Medline] [CrossRef]
44. Matsumura Y, Kuro T, Kobayashi Y, et al.: Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension. Circulation, 2000, 102: 2765–2773. [Medline] [CrossRef]
45. Oyekan AO, McAward K, Conetta J, et al.: Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension. Am J Physiol, 1999, 276: R766–R775. [Medline]
46. i) in contraction of coronary arteries from DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol, 2002, 282: H1944–H1949. [Medline]
47. Seidel CL, Strong R: Metabolic characteristics of aorta from spontaneously hypertensive and renal and deoxycorticosterone acetate-salt hypertensive rats. Hypertension, 1986, 8: 103–108. [Medline] [CrossRef]
48. Tostes RC, Traub O, Bendhack LM, et al.: Sarcoplasmic reticulum Ca2+ uptake is not decreased in aorta from deoxycorticosterone acetate hypertensive rats: functional assessment with cyclopiazonic acid. Can J Physiol Pharmacol, 1995, 73: 1536–1545. [Medline] [CrossRef]
49. Hagen EC, Webb RC: Coronary artery reactivity in deoxycorticosterone acetate hypertensive rats. Am J Physiol, 1984, 247: H409–H414. [Medline]
50. Fink GD, Johnson RJ, Galligan JJ: Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. Hypertension, 2000, 35: 464–469. [Medline] [CrossRef]
51. Dawson R Jr, Nagamhama S, Oparil S: Central serotonergic alterations in deoxycorticosterone acetate/NaCl (DOCA/NaCl)-induced hypertension. Neuropharmacology, 1988, 27: 417–426. [Medline] [CrossRef]
52. 42K turnover during deoxycorticosterone acetate hypertension and antihypertensive therapy in the rat. Circ Res, 1977, 41: 256–260. [Medline] [CrossRef]